HEADER TRANSFERASE/TRANSFERASE INHIBITOR 13-FEB-14 4OTH TITLE CRYSTAL STRUCTURE OF PRK1 CATALYTIC DOMAIN IN COMPLEX WITH RO-31-8220 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE N1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 605-942; COMPND 5 SYNONYM: PROTEASE-ACTIVATED KINASE 1, PAK-1, PROTEIN KINASE C-LIKE 1, COMPND 6 PROTEIN KINASE C-LIKE PKN, PROTEIN KINASE PKN-ALPHA, PROTEIN-KINASE COMPND 7 C-RELATED KINASE 1, SERINE-THREONINE PROTEIN KINASE N; COMPND 8 EC: 2.7.11.13; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PKN1, PAK1, PKN, PRK1, PRKCL1; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS PRK1, PKN1, PROTEIN KINASE C RELATED KINASE 1, KINASE, PROTEIN KEYWDS 2 KINASE, ATP BINDING, PHOSPHORYLATION, TRANSFERASE-TRANSFERASE KEYWDS 3 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR P.P.CHAMBERLAIN,S.DELKER,B.PAGARIGAN,A.MAHMOUDI,P.JACKSON, AUTHOR 2 M.ABBASSIAN,J.MUIR,N.RAHEJA,B.CATHERS REVDAT 2 24-JAN-18 4OTH 1 AUTHOR REVDAT 1 27-AUG-14 4OTH 0 JRNL AUTH P.CHAMBERLAIN,S.DELKER,B.PAGARIGAN,A.MAHMOUDI,P.JACKSON, JRNL AUTH 2 M.ABBASIAN,J.MUIR,N.RAHEJA,B.CATHERS JRNL TITL CRYSTAL STRUCTURES OF PRK1 IN COMPLEX WITH THE CLINICAL JRNL TITL 2 COMPOUNDS LESTAURTINIB AND TOFACITINIB REVEAL LIGAND INDUCED JRNL TITL 3 CONFORMATIONAL CHANGES. JRNL REF PLOS ONE V. 9 03638 2014 JRNL REFN ESSN 1932-6203 JRNL PMID 25111382 JRNL DOI 10.1371/JOURNAL.PONE.0103638 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.29 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 90.9 REMARK 3 NUMBER OF REFLECTIONS : 33191 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1653 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2140 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 84.86 REMARK 3 BIN R VALUE (WORKING SET) : 0.2850 REMARK 3 BIN FREE R VALUE SET COUNT : 97 REMARK 3 BIN FREE R VALUE : 0.3110 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2436 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 302 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.69 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.51000 REMARK 3 B22 (A**2) : 0.06000 REMARK 3 B33 (A**2) : 0.46000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.141 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.150 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.127 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.320 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.914 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2555 ; 0.016 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3466 ; 1.568 ; 1.970 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 310 ; 6.091 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 122 ;34.258 ;22.623 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 424 ;15.684 ;15.035 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 25 ;17.669 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 370 ; 0.109 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1972 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1190 ; 0.205 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1736 ; 0.312 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 257 ; 0.181 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 48 ; 0.133 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 20 ; 0.228 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1581 ; 2.125 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2468 ; 2.828 ; 4.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1111 ; 3.178 ; 4.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 995 ; 4.315 ; 5.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 612 A 704 REMARK 3 RESIDUE RANGE : A 907 A 944 REMARK 3 ORIGIN FOR THE GROUP (A): -11.4952 10.3157 -2.9642 REMARK 3 T TENSOR REMARK 3 T11: -0.0486 T22: -0.0441 REMARK 3 T33: -0.0381 T12: -0.0167 REMARK 3 T13: -0.0121 T23: -0.0297 REMARK 3 L TENSOR REMARK 3 L11: 0.7336 L22: 0.8717 REMARK 3 L33: 1.4204 L12: -0.4431 REMARK 3 L13: -0.5792 L23: 0.6231 REMARK 3 S TENSOR REMARK 3 S11: 0.0210 S12: -0.0313 S13: -0.0050 REMARK 3 S21: 0.0053 S22: -0.0038 S23: 0.0342 REMARK 3 S31: 0.0411 S32: 0.0029 S33: -0.0172 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 705 A 906 REMARK 3 ORIGIN FOR THE GROUP (A): -25.9312 -3.5635 -21.0642 REMARK 3 T TENSOR REMARK 3 T11: -0.0498 T22: -0.0465 REMARK 3 T33: -0.0634 T12: -0.0277 REMARK 3 T13: 0.0059 T23: -0.0439 REMARK 3 L TENSOR REMARK 3 L11: 0.9000 L22: 1.0474 REMARK 3 L33: 0.9311 L12: -0.2170 REMARK 3 L13: -0.0551 L23: -0.1128 REMARK 3 S TENSOR REMARK 3 S11: 0.0506 S12: 0.0593 S13: -0.0653 REMARK 3 S21: 0.0489 S22: -0.0602 S23: 0.0909 REMARK 3 S31: 0.0561 S32: -0.0190 S33: 0.0096 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4OTH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-FEB-14. REMARK 100 THE DEPOSITION ID IS D_1000084927. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33917 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.8 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.04300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.83 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.29500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM TRIS PH 8.5, 150-225MM AMMONIUM REMARK 280 ACETATE, 23-28% PEG 3350, VAPOR DIFFUSION REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.15950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.45150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.09850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.45150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.15950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.09850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 608 REMARK 465 SER A 609 REMARK 465 MET A 610 REMARK 465 LEU A 611 REMARK 465 GLU A 770 REMARK 465 GLY A 771 REMARK 465 MET A 772 REMARK 465 GLY A 773 REMARK 465 TYR A 774 REMARK 465 GLY A 775 REMARK 465 ASP A 776 REMARK 465 ARG A 777 REMARK 465 THR A 778 REMARK 465 SER A 779 REMARK 465 TPO A 780 REMARK 465 PHE A 781 REMARK 465 CYS A 782 REMARK 465 GLY A 783 REMARK 465 THR A 784 REMARK 465 PRO A 785 REMARK 465 GLU A 786 REMARK 465 PHE A 787 REMARK 465 LEU A 788 REMARK 465 ALA A 789 REMARK 465 PRO A 790 REMARK 465 GLU A 791 REMARK 465 VAL A 792 REMARK 465 LEU A 793 REMARK 465 THR A 794 REMARK 465 ASP A 795 REMARK 465 THR A 796 REMARK 465 SER A 797 REMARK 465 TYR A 798 REMARK 465 GLY A 947 REMARK 465 CYS A 948 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 1250 O HOH A 1339 1.93 REMARK 500 O LYS A 769 O HOH A 1327 2.08 REMARK 500 NH2 ARG A 660 O HOH A 1401 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 863 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 716 -131.01 -129.74 REMARK 500 ARG A 745 -52.02 76.79 REMARK 500 ASP A 746 38.37 -87.81 REMARK 500 ASP A 870 -123.16 55.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DRN A 1001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4OTD RELATED DB: PDB REMARK 900 RELATED ID: 4OTG RELATED DB: PDB REMARK 900 RELATED ID: 4OTI RELATED DB: PDB DBREF 4OTH A 611 948 UNP Q16512 PKN1_HUMAN 605 942 SEQADV 4OTH GLY A 608 UNP Q16512 EXPRESSION TAG SEQADV 4OTH SER A 609 UNP Q16512 EXPRESSION TAG SEQADV 4OTH MET A 610 UNP Q16512 EXPRESSION TAG SEQRES 1 A 341 GLY SER MET LEU ARG LYS SER PRO LEU THR LEU GLU ASP SEQRES 2 A 341 PHE LYS PHE LEU ALA VAL LEU GLY ARG GLY HIS PHE GLY SEQRES 3 A 341 LYS VAL LEU LEU SER GLU PHE ARG PRO SER GLY GLU LEU SEQRES 4 A 341 PHE ALA ILE LYS ALA LEU LYS LYS GLY ASP ILE VAL ALA SEQRES 5 A 341 ARG ASP GLU VAL GLU SER LEU MET CYS GLU LYS ARG ILE SEQRES 6 A 341 LEU ALA ALA VAL THR SER ALA GLY HIS PRO PHE LEU VAL SEQRES 7 A 341 ASN LEU PHE GLY CYS PHE GLN THR PRO GLU HIS VAL CYS SEQRES 8 A 341 PHE VAL MET GLU TYR SER ALA GLY GLY ASP LEU MET LEU SEQRES 9 A 341 HIS ILE HIS SER ASP VAL PHE SER GLU PRO ARG ALA ILE SEQRES 10 A 341 PHE TYR SER ALA CYS VAL VAL LEU GLY LEU GLN PHE LEU SEQRES 11 A 341 HIS GLU HIS LYS ILE VAL TYR ARG ASP LEU LYS LEU ASP SEQRES 12 A 341 ASN LEU LEU LEU ASP THR GLU GLY TYR VAL LYS ILE ALA SEQRES 13 A 341 ASP PHE GLY LEU CYS LYS GLU GLY MET GLY TYR GLY ASP SEQRES 14 A 341 ARG THR SER TPO PHE CYS GLY THR PRO GLU PHE LEU ALA SEQRES 15 A 341 PRO GLU VAL LEU THR ASP THR SER TYR THR ARG ALA VAL SEQRES 16 A 341 ASP TRP TRP GLY LEU GLY VAL LEU LEU TYR GLU MET LEU SEQRES 17 A 341 VAL GLY GLU SER PRO PHE PRO GLY ASP ASP GLU GLU GLU SEQRES 18 A 341 VAL PHE ASP SER ILE VAL ASN ASP GLU VAL ARG TYR PRO SEQRES 19 A 341 ARG PHE LEU SER ALA GLU ALA ILE GLY ILE MET ARG ARG SEQRES 20 A 341 LEU LEU ARG ARG ASN PRO GLU ARG ARG LEU GLY SER SER SEQRES 21 A 341 GLU ARG ASP ALA GLU ASP VAL LYS LYS GLN PRO PHE PHE SEQRES 22 A 341 ARG THR LEU GLY TRP GLU ALA LEU LEU ALA ARG ARG LEU SEQRES 23 A 341 PRO PRO PRO PHE VAL PRO THR LEU SER GLY ARG THR ASP SEQRES 24 A 341 VAL SER ASN PHE ASP GLU GLU PHE THR GLY GLU ALA PRO SEQRES 25 A 341 THR LEU SEP PRO PRO ARG ASP ALA ARG PRO LEU THR ALA SEQRES 26 A 341 ALA GLU GLN ALA ALA PHE LEU ASP PHE ASP PHE VAL ALA SEQRES 27 A 341 GLY GLY CYS MODRES 4OTH SEP A 922 SER PHOSPHOSERINE HET SEP A 922 10 HET DRN A1001 33 HETNAM SEP PHOSPHOSERINE HETNAM DRN BISINDOLYLMALEIMIDE IX HETSYN SEP PHOSPHONOSERINE FORMUL 1 SEP C3 H8 N O6 P FORMUL 2 DRN C25 H23 N5 O2 S FORMUL 3 HOH *302(H2 O) HELIX 1 1 THR A 617 GLU A 619 5 3 HELIX 2 2 LYS A 654 ARG A 660 1 7 HELIX 3 3 GLU A 662 SER A 678 1 17 HELIX 4 4 LEU A 709 ILE A 713 1 5 HELIX 5 5 SER A 719 HIS A 740 1 22 HELIX 6 6 LYS A 748 ASP A 750 5 3 HELIX 7 7 ARG A 800 GLY A 817 1 18 HELIX 8 8 ASP A 825 ASP A 836 1 12 HELIX 9 9 SER A 845 LEU A 856 1 12 HELIX 10 10 ASP A 870 LYS A 876 1 7 HELIX 11 11 GLN A 877 ARG A 881 5 5 HELIX 12 12 GLY A 884 ALA A 890 1 7 HELIX 13 13 ASP A 911 GLY A 916 1 6 HELIX 14 14 THR A 931 ALA A 937 1 7 SHEET 1 A 6 PHE A 621 GLY A 630 0 SHEET 2 A 6 GLY A 633 PHE A 640 -1 O LEU A 637 N LEU A 624 SHEET 3 A 6 LEU A 646 LYS A 653 -1 O PHE A 647 N SER A 638 SHEET 4 A 6 HIS A 696 GLU A 702 -1 O MET A 701 N ALA A 648 SHEET 5 A 6 LEU A 687 GLN A 692 -1 N GLY A 689 O VAL A 700 SHEET 6 A 6 PHE A 943 VAL A 944 -1 O PHE A 943 N CYS A 690 SHEET 1 B 3 GLY A 707 ASP A 708 0 SHEET 2 B 3 LEU A 752 LEU A 754 -1 O LEU A 754 N GLY A 707 SHEET 3 B 3 VAL A 760 ILE A 762 -1 O LYS A 761 N LEU A 753 SSBOND 1 CYS A 668 CYS A 768 1555 1555 2.06 LINK C LEU A 921 N SEP A 922 1555 1555 1.34 LINK C SEP A 922 N PRO A 923 1555 1555 1.33 CISPEP 1 LEU A 883 GLY A 884 0 -4.49 SITE 1 AC1 17 LEU A 627 PHE A 632 ALA A 648 VAL A 685 SITE 2 AC1 17 MET A 701 GLU A 702 TYR A 703 SER A 704 SITE 3 AC1 17 ASP A 708 ASP A 750 ASN A 751 LEU A 753 SITE 4 AC1 17 ALA A 763 ASP A 764 PHE A 910 HOH A1233 SITE 5 AC1 17 HOH A1257 CRYST1 56.319 72.197 94.903 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017756 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013851 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010537 0.00000